While Endo is every bit as important medically, I don't think it will be as lucrative commercially.
The proactive monitoring, annual retest, for kidney disease is the differentiator
PIQ $1.00, page-46
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
80.0¢ |
Change
0.010(1.27%) |
Mkt cap ! $104.8M | |||
| Open | High | Low | Value | Volume |
| 79.0¢ | 80.0¢ | 78.0¢ | $68.28K | 86.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7412 | 78.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 81.0¢ | 8000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |